The Innovative Medicines Initiative (IMI) project PREMIER aims to develop a centralised, user-friendly digital assessment system accessible for all relevant stakeholders. PREMIER will also explore options to incorporate environment considerations earlier in the drug development process to inform drug design and to reduce the need of animal testing.
ECT is involved in this project as partner. Together with the industry representative from AstraZeneca, Anja Coors as representative of ECT is leading the work package devoted to generating experimental data for about 25 high-priority pharmaceuticals. In addition, ECT contributes to other work packages.
For more information, see here.